Antituberculosis Drugs (Rifampicin and Isoniazid) Induce Liver Injury by Regulating NLRP3 Inflammasomes
Patients being treated for pulmonary tuberculosis often suffer liver injury due to the effects of anti-TB drugs, and the underlying mechanisms for those injuries need to be clarified. In this study, rats and hepatic cells were administrated isoniazid (INH) and rifampin (RIF) and then treated with NL...
Saved in:
Main Authors: | Qiang Su, Wei Kuang, Weiyi Hao, Jing Liang, Liang Wu, Chunmei Tang, Yali Wang, Tao Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2021/8086253 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hyperuricemia, use of antituberculosis drugs, and liver injury: case report
by: Vina Yuwantari, et al.
Published: (2023-08-01) -
Missed rifampicin and isoniazid resistance by commercial molecular assays
by: L Richards, et al.
Published: (2024-07-01) -
Rifampicin and isoniazid resistance not promote fluoroquinolone resistance in Mycobacterium smegmatis
by: Qin Zhou, et al.
Published: (2025-01-01) -
Rifampicin and isoniazid resistance not promote fluoroquinolone resistance in Mycobacterium smegmatis.
by: Qin Zhou, et al.
Published: (2025-01-01) -
Ginsenoside Rd protects against acute liver injury by regulating the autophagy NLRP3 inflammasome pathway
by: Xiaomei Zhong, et al.
Published: (2025-01-01)